Advertisement

Studying Copy Number Variations in Cell-Free DNA: The Example of AR in Prostate Cancer

  • Samanta SalviEmail author
  • Valentina Casadio
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1909)

Abstract

Serum and plasma cell-free DNA (cfDNA) has been shown as an informative noninvasive source of biomarkers for different diseases, including cancer. Starting from the hypothesis that the gain of androgen receptor (AR) gene is a frequent aberration in advanced prostate cancer patients, we analyzed it in cfDNA as a potential predictive biomarker of specific treatments. Here we report a general protocol that may be considered to analyze gene copy number variations in serum or plasma fluids.

Key words

Androgen receptor AR Cell-free DNA Copy number variation Prostate cancer 

References

  1. 1.
    Feuk L, Carson AR, Scherer SW (2006) Structural variation in the human genome. Nat Rev Genet 7(2):85–97CrossRefGoogle Scholar
  2. 2.
    Siegel RL, Miller KD, Jemal A (2016) Cancer statistics. CA Cancer J Clin 66:7–30CrossRefGoogle Scholar
  3. 3.
    Attard G, Parker C, Eeles RA et al (2016) Prostate cancer. Lancet 387(10013):70–82CrossRefGoogle Scholar
  4. 4.
    Salvi S, Casadio V, Conteduca V et al (2015) Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone. Br J Cancer 112(10):1717–1724CrossRefGoogle Scholar
  5. 5.
    Salvi S, Casadio V, Conteduca V et al (2016) Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer. Oncotarget 7(25):37839–37845CrossRefGoogle Scholar
  6. 6.
    Salvi S, Conteduca V, Martignano F et al (2017) Serum and plasma copy number detection using real-time PCR. J Vis Exp 15(130). https://doi.org/10.3791/56502
  7. 7.
    Trask BJ (1991) Fluorescence in situ hybridization: applications in cytogenetics and gene mapping. Trends Genet 7(5):149–154CrossRefGoogle Scholar
  8. 8.
    Carter NP (2007) Methods and strategies for analyzing copy number variation using DNA microarrays. Nat Genet 39(7 Suppl):S16–S21CrossRefGoogle Scholar
  9. 9.
    Hömig-Hölzel C, Savola S (2012) Multiplex ligation-dependent probe amplification (MLPA) in tumor diagnostics and prognostics. Diagn Mol Pathol 21(4):189–206CrossRefGoogle Scholar
  10. 10.
    Hindson BJ, Ness KD, Masquelier DA et al (2011) High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem 83(22):8604–8610CrossRefGoogle Scholar
  11. 11.
    Korbel JO, Urban AE, Affourtit JP et al (2007) Paired-end mapping reveals extensive structural variation in the human genome. Science 318(5849):420–426CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Biosciences LaboratoryIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCSMeldolaItaly

Personalised recommendations